Annual SGA
$66.92 M
+$33.66 M+101.22%
December 31, 2023
Summary
- As of February 7, 2025, SNDX annual SGA is $66.92 million, with the most recent change of +$33.66 million (+101.22%) on December 31, 2023.
- During the last 3 years, SNDX annual SGA has risen by +$44.42 million (+197.37%).
- SNDX annual SGA is now at all-time high.
Performance
SNDX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$31.11 M
+$2.04 M+7.04%
September 30, 2024
Summary
- As of February 7, 2025, SNDX quarterly SGA is $31.11 million, with the most recent change of +$2.04 million (+7.04%) on September 30, 2024.
- Over the past year, SNDX quarterly SGA has increased by +$13.84 million (+80.14%).
- SNDX quarterly SGA is now at all-time high.
Performance
SNDX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.05 B
-$297.06 M-7.92%
September 30, 2024
Summary
- As of February 7, 2025, SNDX TTM SGA is -$4.05 billion, with the most recent change of -$297.06 million (-7.92%) on September 30, 2024.
- Over the past year, SNDX TTM SGA has dropped by -$4.10 billion (-7548.33%).
- SNDX TTM SGA is now -2882.20% below its all-time high of -$135.71 million.
Performance
SNDX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SNDX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +101.2% | +80.1% | -7548.3% |
| 3 y3 years | +197.4% | +355.0% | -10000.0% |
| 5 y5 years | +287.1% | +355.0% | -10000.0% |
SNDX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.1% | at high | +355.0% | -69.8% | at low |
| 5 y | 5-year | at high | +316.6% | at high | +559.3% | -113.1% | at low |
| alltime | all time | at high | +1815.3% | at high | +4114.9% | -2882.2% | at low |
Syndax Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $31.11 M(+7.0%) | $105.97 M(+15.0%) |
| Jun 2024 | - | $29.06 M(+26.2%) | $92.13 M(+18.1%) |
| Mar 2024 | - | $23.02 M(+1.1%) | $77.98 M(+16.5%) |
| Dec 2023 | $66.92 M(+101.2%) | $22.78 M(+31.9%) | $66.92 M(+23.2%) |
| Sep 2023 | - | $17.27 M(+15.8%) | $54.34 M(+19.9%) |
| Jun 2023 | - | $14.91 M(+24.7%) | $45.31 M(+18.0%) |
| Mar 2023 | - | $11.96 M(+17.4%) | $38.38 M(+15.4%) |
| Dec 2022 | $33.26 M(+31.8%) | $10.19 M(+23.7%) | $33.26 M(+10.9%) |
| Sep 2022 | - | $8.24 M(+3.1%) | $29.99 M(+5.0%) |
| Jun 2022 | - | $7.99 M(+16.9%) | $28.55 M(+8.1%) |
| Mar 2022 | - | $6.84 M(-1.3%) | $26.41 M(+4.6%) |
| Dec 2021 | $25.24 M(+12.2%) | $6.93 M(+1.9%) | $25.24 M(+9.6%) |
| Sep 2021 | - | $6.80 M(+16.4%) | $23.03 M(+4.4%) |
| Jun 2021 | - | $5.84 M(+3.0%) | $22.06 M(-0.9%) |
| Mar 2021 | - | $5.67 M(+20.2%) | $22.26 M(-1.1%) |
| Dec 2020 | $22.50 M(+40.1%) | $4.72 M(-19.0%) | $22.50 M(-1.6%) |
| Sep 2020 | - | $5.82 M(-3.7%) | $22.87 M(+10.7%) |
| Jun 2020 | - | $6.05 M(+2.2%) | $20.65 M(+14.3%) |
| Mar 2020 | - | $5.92 M(+16.4%) | $18.07 M(+12.5%) |
| Dec 2019 | $16.06 M(-7.1%) | $5.08 M(+41.0%) | $16.06 M(+8.0%) |
| Sep 2019 | - | $3.60 M(+4.1%) | $14.87 M(-3.4%) |
| Jun 2019 | - | $3.46 M(-11.5%) | $15.39 M(-6.2%) |
| Mar 2019 | - | $3.91 M(+0.5%) | $16.41 M(-5.1%) |
| Dec 2018 | $17.29 M | $3.89 M(-5.6%) | $17.29 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $4.13 M(-7.9%) | $17.48 M(+3.3%) |
| Jun 2018 | - | $4.48 M(-6.5%) | $16.92 M(+1.2%) |
| Mar 2018 | - | $4.79 M(+17.3%) | $16.72 M(+5.4%) |
| Dec 2017 | $15.86 M(+19.1%) | $4.08 M(+14.6%) | $15.86 M(+7.5%) |
| Sep 2017 | - | $3.56 M(-16.8%) | $14.75 M(+2.0%) |
| Jun 2017 | - | $4.29 M(+9.0%) | $14.46 M(+11.4%) |
| Mar 2017 | - | $3.93 M(+32.2%) | $12.98 M(-2.6%) |
| Dec 2016 | $13.32 M(+14.9%) | $2.97 M(-9.1%) | $13.32 M(+4.5%) |
| Sep 2016 | - | $3.27 M(+16.4%) | $12.75 M(+0.6%) |
| Jun 2016 | - | $2.81 M(-34.3%) | $12.67 M(-3.6%) |
| Mar 2016 | - | $4.27 M(+78.2%) | $13.15 M(+13.5%) |
| Dec 2015 | $11.59 M(+3.9%) | $2.40 M(-25.0%) | $11.59 M(+5.1%) |
| Sep 2015 | - | $3.19 M(-2.8%) | $11.03 M(-20.4%) |
| Jun 2015 | - | $3.29 M(+21.3%) | $13.86 M(+15.3%) |
| Mar 2015 | - | $2.71 M(+47.8%) | $12.02 M(+7.8%) |
| Dec 2014 | $11.16 M(+108.0%) | $1.83 M(-69.6%) | $11.16 M(+0.1%) |
| Sep 2014 | - | $6.03 M(+315.7%) | $11.14 M(+70.0%) |
| Jun 2014 | - | $1.45 M(-21.5%) | $6.55 M(+1.3%) |
| Mar 2014 | - | $1.85 M(+1.4%) | $6.47 M(+20.7%) |
| Dec 2013 | $5.36 M(+53.5%) | $1.82 M(+26.5%) | $5.36 M(+51.4%) |
| Sep 2013 | - | $1.44 M(+5.3%) | $3.54 M(+68.4%) |
| Jun 2013 | - | $1.37 M(+85.1%) | $2.10 M(+185.1%) |
| Mar 2013 | - | $738.00 K | $738.00 K |
| Dec 2012 | $3.49 M | - | - |
FAQ
- What is Syndax Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual SGA year-on-year change?
- What is Syndax Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly SGA year-on-year change?
- What is Syndax Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals TTM SGA year-on-year change?
What is Syndax Pharmaceuticals annual SGA?
The current annual SGA of SNDX is $66.92 M
What is the all time high annual SGA for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual SGA is $66.92 M
What is Syndax Pharmaceuticals annual SGA year-on-year change?
Over the past year, SNDX annual SGA has changed by +$33.66 M (+101.22%)
What is Syndax Pharmaceuticals quarterly SGA?
The current quarterly SGA of SNDX is $31.11 M
What is the all time high quarterly SGA for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly SGA is $31.11 M
What is Syndax Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, SNDX quarterly SGA has changed by +$13.84 M (+80.14%)
What is Syndax Pharmaceuticals TTM SGA?
The current TTM SGA of SNDX is -$4.05 B
What is the all time high TTM SGA for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high TTM SGA is -$135.71 M
What is Syndax Pharmaceuticals TTM SGA year-on-year change?
Over the past year, SNDX TTM SGA has changed by -$4.10 B (-7548.33%)